Clinical Trial Update: Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluated Extracorporeal Photopheresis given before or after allogeneic bone marrow or peripheral blood stem cell transplantation to prev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Extracorporeal Photopheresis

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Stem Cell Leukemia of Unclear Lineage, Graft Versus Host Disease | EARLY_Phase 1 | Status: COMPLETED